Concurrent antibiosis and anti-inflammation against bacterial pneumonia by zinc hexacyanoferrate nanocatalysts
Source abstract
Abstract
The bacterial pneumonia has been demonstrated to cause acute and severe pathological lung injury as well as the uncontrollable oxidative cytokine storms. The effective therapeutics against bacterial pneumonia demands highly efficient pathogen elimination, oxidative stress alleviation and anti-inflammation. Nevertheless, current therapeutics fail to achieve these goals by a single medicine with satisfactory performance. Herein, we report a self-assembled zinc-doped prussian blue-analogue - zinc hexacyanoferrate nanocatalysts (ZnPBA NCs) possessing excellent broad-spectrum anti-bacterial activity and antioxidative catalytic activities against multiple reactive oxygen species (ROS) and the associated cytokine storm as well. By employing various oxidative substances and in vivo murine bacterial pneumoniae models, we verified that the synthetic zinc hexacyanoferrate nanocatalysts could concurrently eliminate the bacterial infection and largely alleviate infection-induced oxidative stress and inflammation, demonstrating the promising clinical application potentials against diverse bacterial infection-related diseases.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Advanced Nanomaterials in Catalysis · Pneumocystis jirovecii pneumonia detection and treatment · Nanoplatforms for cancer theranostics
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (34)
Show source-provided references
1. Cytokine storm10.1056/NEJMra2026131 ↗
2. Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty10.1038/s41569-018-0064-2 ↗
3. Neutrophil recruitment and function in health and inflammation10.1038/nri3399 ↗
4. Acute infection and myocardial infarction10.1056/NEJMra1808137 ↗
5. Chronic inflammation in the etiology of disease across the life span10.1038/s41591-019-0675-0 ↗
6. Reactive oxygen species in inflammation and tissue injury, antioxid10.1089/ars.2012.5149 ↗
7. Inflammasomes: mechanism of action, role in disease, and therapeutics10.1038/nm.3893 ↗
8. Viral pneumonia10.1016/S0140-6736(10)61459-6 ↗
9. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia10.1164/rccm.200405-644ST ↗
10. Existing and potential therapeutic uses for N-acetylcysteine: the need for conversion to intracellular glutathione for antioxidant benefits10.1016/j.pharmthera.2013.09.006 ↗
11. Reactive oxygen species (ROS)-Based nanomedicine10.1021/acs.chemrev.8b00626 ↗
12. Integrated cascade nanozyme catalyzes in vivo ROS scavenging for anti-inflammatory therapy10.1126/sciadv.abb2695 ↗
13. Nanocatalytic medicine of iron-based nanocatalysts10.31635/ccschem.020.202000519 ↗
14. A single-atom nanozyme for wound disinfection applications10.1002/anie.201813994 ↗
15. Enhanced photocatalytic activity and photothermal effects of cu-doped metal-organic frameworks for rapid treatment of bacteria-infected wounds10.1016/j.apcatb.2019.118248 ↗
16. Enhanced antibacterial activity of nanocrystalline ZnO due to increased ROS-mediated cell injury10.1002/adfm.200801081 ↗
17. Ultrasmall copper-based nanoparticles for reactive oxygen species scavenging and alleviation of inflammation related diseases
18. Anti-inflammatory properties of cerium oxide nanoparticles10.1002/smll.200901048 ↗
19. Polyphenol-binding amyloid fibrils self-assemble into reversible hydrogels with antibacterial activity10.1021/acsnano.7b08969 ↗
20. Assembly of metal–phenolic/catecholamine networks for synergistically anti-inflammatory, antimicrobial, and anticoagulant coatings10.1021/acsami.8b14409 ↗
21. Self-assembly hollow manganese Prussian white nanocapsules attenuate Tau-related neuropathology and cognitive decline10.1016/j.biomaterials.2019.119678 ↗
22. Reactive oxygen species scavenging and inflammation mitigation enabled by biomimetic prussian blue analogues boycott atherosclerosis
23. Prussian blue nanozyme-mediated nanoscavenger ameliorates acute pancreatitis via inhibiting TLRs/NF-kappa B signaling pathway10.7150/thno.52010 ↗
24. Pd ion‐exchange and ammonia etching of a prussian blue analogue to produce a high‐performance water‐splitting catalyst10.1002/adfm.202008989 ↗
25. Prussian blue nanoparticles as multienzyme mimetics and reactive oxygen species scavengers10.1021/jacs.5b12070 ↗
26. Electrochemistry of polynuclear transition metal cyanides: prussian blue and its analogues10.1021/ar00126a001 ↗
27. Electrochromism in the mixed-valence hexacyanides. 1. Voltammetric and spectral studies of the oxidation and reduction of thin films of Prussian blue10.1021/j150609a026 ↗
28. Reactive oxygen species (ROS) as pleiotropic physiological signalling agents10.1038/s41580-020-0230-3 ↗
29. Hydrogen peroxide mediates the cell growth and transformation caused by the mitogenic oxidase Nox 110.1073/pnas.101505898 ↗
30. Innate immune sensing and its roots: the story of endotoxin10.1038/nri1004 ↗
31. Oxidative stress, inflammation, and cancer: how are they linked?10.1016/j.freeradbiomed.2010.09.006 ↗
32. Antioxidant and anti-inflammatory effects of zinc. Zinc-dependent NF-κB signaling10.1007/s10787-017-0309-4 ↗
33. Neutrophil-mediated delivery of therapeutic nanoparticles across blood vessel barrier for treatment of inflammation and infection10.1021/acsnano.5b05583 ↗
34. Calming cytokine storm in pneumonia by targeted delivery of TPCA-1 using platelet-derived extracellular vesicles10.1016/j.matt.2020.05.017 ↗